Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2014

01-12-2014 | Breast Oncology

Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey

Authors: Peter D. Beitsch, MD, FACS, Pat W. Whitworth, MD

Published in: Annals of Surgical Oncology | Issue 13/2014

Login to get access

Abstract

Background

Whether breast cancer surgeons are adequately trained, skilled, and experienced to provide breast cancer genetic assessment, testing, and counseling came under debate in September 2013 when a major third-party payer excluded nongenetics specialists from ordering such testing. A literature search having failed to uncover any study on breast surgeons’ skill and practice in this area, the American Society of Breast Surgeons (ASBrS) surveyed its members on their experience with the recognized crucial components of such testing.

Methods

In late 2013, ASBrS e-mailed a link to an online questionnaire to its U.S. members (n = 2,603) requesting a self-assessment of skills and experience in genetic assessment, testing, interpretation, and counseling. After approximately 6 weeks, the results were collated and evaluated.

Results

By January 2, 2014, 907 responses (34.84 %) had arrived from breast surgeons nationwide working in academic settings (20 %), solo or small group private practice (39 %), large multispecialty groups (18 %), and other settings. More than half said they performed 3-generation pedigrees, ordered genetic testing, and provided pre- and posttest counseling. Most noted that they would welcome continuing educational support in genetics.

Conclusions

Currently the majority of breast surgeons provide genetic counseling and testing services to their patients. They report practices that meet or exceed recognized guidelines, including the necessary elements and processes for best practices in breast cancer genetics test counseling. Because breast cancer genetic testing is grossly underutilized relative to the size of the U.S. BRCA mutation carrier population, these appropriate services should not be restricted but rather supported and expanded.
Literature
1.
go back to reference Cho MK, Sankar P, Wolpe PR, Godmilow L. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test. Am J Med Genet. 1999;83:157–63.PubMedCentralPubMedCrossRef Cho MK, Sankar P, Wolpe PR, Godmilow L. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test. Am J Med Genet. 1999;83:157–63.PubMedCentralPubMedCrossRef
2.
go back to reference American College of Surgeons Cancer Programs. National Accreditation Program for Breast Centers: background statement. Available at: http://napbc-breast.org/. Accessed January 28, 2014. American College of Surgeons Cancer Programs. National Accreditation Program for Breast Centers: background statement. Available at: http://​napbc-breast.​org/​. Accessed January 28, 2014.
3.
go back to reference Genetic Evaluation and Management. Standard 2.16. Cancer risk assessment, genetic counseling and genetic testing services are provided or referred. In: 2013 breast center standards manual. National Accreditation Program for Breast Centers. Chicago, IL: American College of Surgeons; 2013. Available at: http://napbc-breast.org/standards/2013standardsmanual.pdf#52. Accessed January 29, 2014. Genetic Evaluation and Management. Standard 2.16. Cancer risk assessment, genetic counseling and genetic testing services are provided or referred. In: 2013 breast center standards manual. National Accreditation Program for Breast Centers. Chicago, IL: American College of Surgeons; 2013. Available at: http://​napbc-breast.​org/​standards/​2013standardsman​ual.​pdf#52. Accessed January 29, 2014.
6.
go back to reference Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19:1732–7.PubMedCrossRef Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19:1732–7.PubMedCrossRef
7.
go back to reference Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MJ. Who are we and what do we think? Am J Surg. 2003;186:321–3.PubMedCrossRef Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MJ. Who are we and what do we think? Am J Surg. 2003;186:321–3.PubMedCrossRef
8.
go back to reference Schubart JR, Dominici LS, Farnan M, et al. Shared decision making in breast cancer: national practice patterns of surgeons. Ann Surg Oncol. 2013;20:3323–9.PubMedCrossRef Schubart JR, Dominici LS, Farnan M, et al. Shared decision making in breast cancer: national practice patterns of surgeons. Ann Surg Oncol. 2013;20:3323–9.PubMedCrossRef
9.
go back to reference Chipman J, Drohan B, Blackford A, Parmigiani G, Hughes K, Bosinoff P. Providing access to risk prediction tools via the HL7 XML-formatted risk Web service. Breast Cancer Res Treat. 2013;140:187–93.PubMedCentralPubMedCrossRef Chipman J, Drohan B, Blackford A, Parmigiani G, Hughes K, Bosinoff P. Providing access to risk prediction tools via the HL7 XML-formatted risk Web service. Breast Cancer Res Treat. 2013;140:187–93.PubMedCentralPubMedCrossRef
10.
go back to reference Lu KH, Wood ME, Daniels M, et al. American Society of Clinical Oncology expert statement: collection and use of a cancer family history for oncology providers. J Clin Oncol., 2014; 32(8):833–40.PubMedCrossRef Lu KH, Wood ME, Daniels M, et al. American Society of Clinical Oncology expert statement: collection and use of a cancer family history for oncology providers. J Clin Oncol., 2014; 32(8):833–40.PubMedCrossRef
11.
go back to reference Biswas S, Atienza P, Chipman J, et al. Simplifying clinical use of the genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2013;139:571–9.PubMedCentralPubMedCrossRef Biswas S, Atienza P, Chipman J, et al. Simplifying clinical use of the genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2013;139:571–9.PubMedCentralPubMedCrossRef
16.
go back to reference Schwartz MD, Valdimarsdottir HB, Peshkin BN, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014, 32(7):618–26.PubMedCrossRef Schwartz MD, Valdimarsdottir HB, Peshkin BN, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014, 32(7):618–26.PubMedCrossRef
17.
go back to reference Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? J Clin Oncol. 2014; 32(7):611–2.PubMedCrossRef Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? J Clin Oncol. 2014; 32(7):611–2.PubMedCrossRef
Metadata
Title
Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey
Authors
Peter D. Beitsch, MD, FACS
Pat W. Whitworth, MD
Publication date
01-12-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 13/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3711-9

Other articles of this Issue 13/2014

Annals of Surgical Oncology 13/2014 Go to the issue